These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29871226)

  • 1. [Effect of smart-phone application on complications of chemoradiotherapy and quality of life in patients with nasopharyngeal carcinoma].
    Di RQ; Li GW; Zhao YL; Li XD
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(3):215-218. PubMed ID: 29871226
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy.
    Zhao C; Chen J; Yu B; Chen X
    Int J Radiat Biol; 2014 Oct; 90(10):853-8. PubMed ID: 24758521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Home Nursing Intervention on the Quality of Life of Patients with Nasopharyngeal Carcinoma after Radiotherapy and Chemotherapy.
    Shi RC; Meng AF; Zhou WL; Yu XY; Huang XE; Ji AJ; Chen L
    Asian Pac J Cancer Prev; 2015; 16(16):7117-21. PubMed ID: 26514499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a Smartphone Medical App Improves Complications and Quality of Life in Patients with Nasopharyngeal Carcinoma Who Underwent Radiotherapy and Chemotherapy.
    Di R; Li G
    Med Sci Monit; 2018 Sep; 24():6151-6156. PubMed ID: 30178780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of an Intervention to Promote Self-Efficacy on Quality of Life of Patients with Nasopharyngeal Carcinoma of the Zhuang Tribe Minority in Guangxi, China: A Prospective Study.
    Lu J; Zeng X; Liao J; Zhang Y; Yang L; Li Y; Lv J
    Med Sci Monit; 2017 Aug; 23():4077-4086. PubMed ID: 28832557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of resistance exercise on complications, cancer-related fatigue and quality of life in nasopharyngeal carcinoma patients undergoing chemoradiotherapy: A randomised controlled trial.
    Hu Q; Zhao D
    Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13355. PubMed ID: 33159422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.
    Guo SP; Wu SG; Zhou J; Feng HX; Li FY; Wu YJ; Sun JY; He ZY
    Drug Des Devel Ther; 2014; 8():497-503. PubMed ID: 24872680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of recombinant human interleukin-11 treatment on prognosis of patients with radiochemoradiotherapy in the treatment of nasopharyngeal carcinoma].
    Pan Y; Wu H; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(12):945-948. PubMed ID: 29798418
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of endoscopic sinus surgery on the quality of life of patients with early nasopharyngeal carcinoma and the analysis of prognosis-related factors.
    Si YF; Lan GP; Deng ZX; Weng JJ; Si JY; Qin YD; Huang B; Wang YL; Yang Y; Qin Y; Zhang BJ; Han X; Xiong WM
    Tumour Biol; 2017 Jul; 39(7):1010428317707435. PubMed ID: 28714364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction Chemotherapy plus Concurrent Chemoradiotherapy vs Concurrent Chemoradiotherapy in Elderly Patients with Advanced Nasopharyngeal Carcinoma.
    Wang C; Tang X; Wang J; Song J; Xu Y
    Otolaryngol Head Neck Surg; 2017 Aug; 157(2):233-238. PubMed ID: 28418781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma.
    Oates JE; Clark JR; Read J; Reeves N; Gao K; Jackson M; Boyer M; O'brien CJ
    Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):533-40. PubMed ID: 17576902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH
    Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
    Li Y; Chen QY; Tang LQ; Liu LT; Guo SS; Guo L; Mo HY; Chen MY; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Shao JY; Sun Y; Tan J; Chen S; Ma J; Zhao C; Mai HQ
    BMC Cancer; 2017 Aug; 17(1):567. PubMed ID: 28836950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of long-term effects between induction chemotherapy and concurrent chemotherapy on patients with local advanced nasopharyngeal carcinoma].
    Wang HB; Chen Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):361-365. PubMed ID: 29871262
    [No Abstract]   [Full Text] [Related]  

  • 15. Waldeyer ring microbiome in relation to chemoradiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
    Chung A; Chung YT; Liang YW; Chung YL
    Head Neck; 2023 Aug; 45(8):2047-2057. PubMed ID: 37337976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up.
    You R; Hua YJ; Liu YP; Yang Q; Zhang YN; Li JB; Li CF; Zou X; Yu T; Cao JY; Zhang MX; Jiang R; Sun R; Mo HY; Guo L; Cao KJ; Lin AH; Sun Y; Qian CN; Ma J; Chen MY
    Theranostics; 2017; 7(8):2314-2324. PubMed ID: 28740554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical observation of sarcandra glabra combined chemoradiotherapy for treating patients with local advanced nasopharyngeal carcinoma].
    Huang DN; Huang HX; Lu Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Apr; 33(4):456-8. PubMed ID: 23841261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma.
    Yin J; Xie J; Lin J; Weng C; Lu S; Xu P; Zhang S; Luo C; Huang Y; Li L; Lang J; Feng M
    Cancer Biol Ther; 2022 Dec; 23(1):27-33. PubMed ID: 34989325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma.
    Imano N; Murakami Y; Nakashima T; Takeuchi Y; Takahashi I; Doi Y; Nishibuchi I; Kimura T; Wadasaki K; Ueda T; Hirakawa K; Nagata Y
    Jpn J Radiol; 2017 Nov; 35(11):673-680. PubMed ID: 28887732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.
    Du CR; Ying HM; Kong FF; Zhai RP; Hu CS
    Radiat Oncol; 2015 Mar; 10():70. PubMed ID: 25889937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.